Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

L Yu, J Wei, P Liu - Seminars in cancer biology, 2022 - Elsevier
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …

Clinical update on head and neck cancer: molecular biology and ongoing challenges

E Alsahafi, K Begg, I Amelio, N Raulf, P Lucarelli… - Cell death & …, 2019 - nature.com
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically
complex and difficult to treat group of cancers. In lieu of truly effective targeted therapies …

Targeted therapy for head and neck cancer: signaling pathways and clinical studies

Q Li, Y Tie, A Alu, X Ma, H Shi - Signal transduction and targeted …, 2023 - nature.com
Head and neck cancer (HNC) is malignant, genetically complex and difficult to treat and is
the sixth most frequent cancer, with tobacco, alcohol and human papillomavirus being major …

PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer

FE Marquard, M Jücker - Biochemical pharmacology, 2020 - Elsevier
The aim of this review is to summarize current available information about the role of
PI3K/AKT/mTOR signaling in head and neck cancer as a potential target for new therapy …

Inhibition of the PI3K/AKT/mTOR pathway in solid tumors

PM LoRusso - Journal of clinical oncology, 2016 - ascopubs.org
The phosphoinositide 3-kinase (PI3K) pathway plays an integral role in many cellular
processes and is frequently altered in cancer, contributing to tumor growth and survival …

PTEN/PTENP1:'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy

N Haddadi, Y Lin, G Travis, AM Simpson, NT Nassif… - Molecular cancer, 2018 - Springer
Regulation of the PI-3 kinase (PI3K)/Akt signalling pathway is essential for maintaining the
integrity of fundamental cellular processes, cell growth, survival, death and metabolism, and …

Targeting AKT/mTOR in oral cancer: mechanisms and advances in clinical trials

C Harsha, K Banik, HL Ang, S Girisa… - International journal of …, 2020 - mdpi.com
Oral cancer (OC) is a devastating disease that takes the lives of lots of people globally every
year. The current spectrum of treatment modalities does not meet the needs of the patients …

Head and neck cancer: Current challenges and future perspectives

GR Bhat, RG Hyole, J Li - Advances in Cancer Research, 2021 - Elsevier
Head and neck cancers are a heterogeneous, aggressive and genetically complex
collection of malignancies of the oral cavity, nasopharynx, oropharynx, hypopharynx, larynx …

Identification of novel MicroRNAs and their diagnostic and prognostic significance in oral cancer

L Falzone, G Lupo, GRM La Rosa, S Crimi, CD Anfuso… - Cancers, 2019 - mdpi.com
Background: Oral cancer is one of the most prevalent cancers worldwide. Despite that the
oral cavity is easily accessible for clinical examinations, oral cancers are often not promptly …

Chlorpromazine, an antipsychotic agent, induces G2/M phase arrest and apoptosis via regulation of the PI3K/AKT/mTOR-mediated autophagy pathways in human oral …

AJ Jhou, HC Chang, CC Hung, HC Lin, YC Lee… - Biochemical …, 2021 - Elsevier
Abstract Chlorpromazine (CPZ), an FDA-approved phenothiazine derivative used to treat
schizophrenia and other psychiatric disorders, has been demonstrated to have potential anti …